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Abstract
Introduction: With prolonged storage times, cell membranes of red blood cells (RBCs) undergo morphologic and
biochemical changes, termed ‘RBC storage lesions’. Storage lesions may promote inflammation and thrombophilia
when transfused. In trauma patients, RBC transfusion was an independent risk factor for deep vein thrombosis
(DVT), specifically when RBC units were stored > 21 days or when 5 or more units were transfused. The objective
of this study was to determine if RBC transfusions or RBC storage age predicts incident DVT in medical or surgical
intensive care unit (ICU) patients.
Methods: Using a database which prospectively enrolled 261 patients over the course of 1 year with an ICU stay
of at least 3 days, we analyzed DVT and RBC transfusions using Cox proportional hazards regression. Transfusions
were analyzed with 4 thresholds, and storage age using 3 thresholds. DVTs were identified by twice-weekly
proximal leg ultrasounds. Multivariable analyses were adjusted for 4 significant DVT predictors in this population
(venous thrombosis history, chronic dialysis, platelet transfusion and inotropes).
Results: Of 261 patients, 126 (48.3%) had at least 1 RBC transfusion; 46.8% of those transfused had ≥ 5 units in ICU.
Patients receiving RBCs were older (68.8 vs 64.1 years), more likely to be female (47.0 vs 30.7), sicker (APACHEII 26.8
vs 24.4), and more likely to be surgical (21.4 vs 8.9) (P < 0.05). The total number of RBCs per patient was 1-64,
mean was 6.3 (SD 7.5), median was 4 (IQR 2,8). In univariate analyses, there was no association between DVT and
RBC exposure (1 day earlier, 3 days earlier, 7 days earlier, or ever) or RBC storage (≤ 7 or > 7 days, ≤ 14 or > 14
days, ≤ 21 or > 21 days). Among patients transfused, no multivariable analyses showed that RBC transfusion or
storage age predicted DVT. Trends were counter to the hypothesis (e.g., RBC storage for ≤ 7 days suggested a
higher DVT risk compared to > 7 days (HR 5.3; 95% CI 1.3-22.1).
Conclusions: We were unable to detect any association between RBC transfusions or prolonged red cell storage
and increased risk of DVT in medical or surgical ICU patients. Alternate explanations include a lack of sufficient
events or patients’ interaction, between patient groups, a mixing of red cell storage times creating differential
effects on DVT risk, and unmeasured confounders.
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Over 24 million units of packed red blood cells (RBCs)
were transfused in the US in 2004. More than 40% of
critical care patients receive RBC transfusions while in
the intensive care unit (ICU) [1,2]. Numerous studies
demonstrate that RBC transfusions are associated with
complications in critically ill patients, including volume
overload, acute lung injury, hemolytic reactions,
increased risk of infection, multiple organ dysfunction,
and death [3-6].
Units of packed RBCs can be stored for up to 42 days
after donation. With increasing age, the membranes of
RBCs undergo morphologic and biochemical changes,
termed ‘RBC storage lesions’ [7]. Storage produces a
predictable change in morphology - starting from the
deformable biconcave disc to a reversibly deformed
ecchinocyte to an irreversibly deformed spheroecchino-
cyte [8]. In addition to these morphologic changes and
their consequences, predictable biochemical and oxida-
tive changes occur over prolonged storage. Cardo and
colleagues [9] showed that stored RBCs have membrane
biochemical changes, such as upregulated phosphatidyl-
serine on their surface, that may promote inflammation
and a tendency toward thrombosis [8,9]. RBC mem-
brane microparticle production increases with storage
duration, and these bioactive lipids have been demon-
strated to have proinflammatory, immune-suppressive,
and procoagulant properties [10]. A prior study has also
demonstrated that immumodulation [6] and impaired
vasoregulation occurred with prolonged storing of units
and that poor tissue perfusion was a result [11].
RBC transfusion was found to be an independent risk
factor for deep vein thrombosis (DVT) in 716 trauma
patients (odds ratio 1.74, 95% confidence interval (CI)
1.03 to 2.93) [12,13]. Duration of storage may modify
this risk. In a study of 202 trauma patients transfused
more than 5 units of RBCs, DVT rates were lower
among patients receiving RBCs stored fewer than 28
days compared with more than 28 days (16.7% versus
34.5%, P = 0.006); mortality was also higher among
patients receiving blood with longer storage times
(13.9% versus 26.7%, P = 0.02) [14]. Conflicting evidence
exists, and, to date, no transfusion policy changes in
regard to the age of blood have been made or are war-
ranted on the basis of the data currently available.
Recent feasibility studies cite a potential negative impact
on RBC availability if RBC age transfusion policies are
implemented [15]. Furthermore, there is no current evi-
dence of the relationship between age of blood and
units of transfusion in medical or surgical ICU patients.
These patients represent a new demographic and some
of them will have lower APACHE II (Acute Physiology
and Chronic Health Evaluation II) scores than the
trauma population. If storage lesions are indeed
thrombophilic, the age of blood may present an
increased risk of DVT irrespectively of the patient popu-
lation. The objective of this study was to determine
whether either the number of RBC transfusions or the
age of RBCs transfused was a predictor of the develop-
ment of DVT in medical or surgical ICU patients.
Materials and methods
Study population
We used a prospective study database of 261 critically ill
patients admitted to an academic, 15-bed ICU from Jan-
uary 2001 to January 2002. Inclusion criteria were age of
more than 18 years and an expected ICU stay of greater
than 72 hours. Patients were excluded if they had an
admitting diagnosis of trauma or orthopedic surgery or
if they were pregnant or expected to undergo withdra-
wal of life support. Patients were followed until death or
discharge from the hospital. Substitute decision makers
or patients provided written informed consent to parti-
cipate. The research ethics board of St. Joseph’s Hospital
(Hamilton, ON, Canada) approved this protocol.
In the original study database, we had collected base-
line characteristics such as age, sex, admission diagnosis,
APACHE II score, and organ function. During the ICU
stay, data was collected on transfusion history, advanced
life support measures and VTE risk factors. The restric-
tive RBC transfusion threshold from the TRICC (Trans-
fusion Requirements in Critical Care) trial [3] was in
place as the standard of care in this hospital at the time
of this study. That is, the transfusion trigger was a
hemoglobin target of 70 g/dL unless patients were
actively bleeding or had coronary ischemia. For purposes
of this study on the relation between RBC transfusion
and DVT, one of the investigators (CK) retrospectively
abstracted additional data on these patients from the
medical record, Transfusion Medicine databases (Life-
Line; Mediware Information Systems Inc., Lenexa, KS,
USA), and Canadian Blood Services logs. The duration
of storage for each RBC unit and the total number of
units transfused were documented. Reliability was
ensured by the consistency of the two databases. Trans-
fused units were not leukodepleted at this time. At the
time of this study, Canadian Blood Services did not have
policies about the age of blood. However, the standard
of practice in our blood bank is to issue the oldest avail-
able unit of electronically crossmatch-confirmed blood.
Deep vein thrombosis diagnosis
Twice-weekly lower limb compression ultrasounds were
used to diagnose proximal DVT and were performed in
all patients. A DVT was defined as a non-compressible
v e n o u ss e g m e n td e t e c t e db yu l t r a s o u n di na n yo ft h e
following six sites: trifurcation of the deep calf veins,
distal popliteal vein, proximal popliteal vein, distal
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vein. The ultrasound report noted whether the vessel
was fully compressible, fully compressible with intralum-
inal filling defects, not fully compressible, or not visua-
lized. Patients with positive or indeterminate ultrasound
underwent bilateral lower extremity ascending contrast
venography unless they had absolute contraindications.
Investigations for thrombosis at other anatomical sites
were performed only if clinically indicated.
To ensure uniformity of DVT screen ultrasounds, two
trained ultrasonographers performed all tests indepen-
dently of each other and were blinded to patient history
and physical examinations. A previous inter-rater relia-
bility study demonstrated perfect agreement between
these two ultrasonographers at all six venous sites [16].
To avoid overestimation of DVT incidence because of
an omission of DVT prophylaxis, a DVT prophylaxis
regimen was instituted. Patients received 5,000 units of
unfractionated heparin subcutaneously twice daily. If
there was a contraindication to heparin, pneumatic
compression stockings or antiembolic stockings were
used.
Statistical analysis
We examined the association of DVT with RBC transfu-
sions by using Cox proportional hazards regression and
time-dependent covariates. Time-dependent covariates
a l l o wf o rac h a n g ei nr i s kp r o f i l e so v e rt i m e .F o re x a m -
ple, a patient, in theory, could be at higher risk if a
transfusion was given on the previous day but not if the
transfusion was given a day or more before that. The
temporal relationship was analyzed with four thresholds
(transfusion 1 day earlier, 3 days earlier, 7 days earlier,
or ever before). Transfused RBC storage age was ana-
lyzed by using three sliding thresholds (not more than 7
or more than 7 days, not more than 14 or more than 14
days, and not more than 21 or more than 21 days).
Those patients who did not receive a transfusion were
included with the ‘lower risk’ shorter storage group in
regression analyses. If a patient received more than one
RBC unit on a single day, we categorized the patient on
the basis of their oldest unit.
Independent variables included were baseline factors
(patient age, sex, and body mass index); admission diag-
nosis; medical or surgical admitting diagnosis; APACHE
II score; pre-ICU location; personal or family history of
venous thromboembolism (VTE) disease; known throm-
bophilic disorder; active malignancy (defined as active
malignancy or treatment for active malignancy within
the previous 6 months); chronic cardiac, respiratory,
renal, or central nervous system disease; smoking; hospi-
talization within the previous 6 months; surgery within
the previous 12 weeks; bed rest for at least 3 days in the
previous 4 weeks; and activity level (totally independent,
somewhat limited, or severely limited). Additional fac-
tors included exposures documented within 2 weeks
before ICU admission and daily thereafter (central
venous catheters, subcutaneous unfractionated heparin,
heparin for catheter patency, therapeutic unfractionated
heparin or low-molecular-weight heparin, warfarin, acet-
ylsalicyclic acid, non-steroidal anti-inflammatory drugs,
other anti-platelet drugs, vitamin K, RBCs, fresh frozen
plasma, platelets, and cryoprecipitate). No patient
received recombinant factor VIIa during this study.
Additional independent variables included daily ICU
parameters such as the multiorgan dysfunction score,
mechanical ventilation, vasopressors/inotropes, dialysis,
surgical interventions, hemoglobin, platelet count, inter-
national normalized ratio, partial thromboplastin time,
and intravenous bolus or continuous infusion of seda-
tives, paralytics, or opiates.
We first conducted a univariable analysis testing the
association between RBC transfusion and RBC storage
time with DVT. We then conducted multivariable Cox
proportion analyses, which were adjusted for the four
previously identified significant DVT risk factors in this
population (history of previous VTE, end-stage renal
disease requiring chronic dialysis, platelet transfusion,
and inotropes/vasopressors) [17,18]. For the final model,
we calculated hazard ratios and 95% CIs for all variables
s i g n i f i c a n ta taP value of less than 0.05. We tested for
interactions among significant factors in the final model.
We also evaluated whether risk factors varied over the
ICU stay by using a non-proportional hazard Cox model
and testing the interaction of each variable with time.
We used the computer program SAS (statistical analysis
software) (SAS Institute Inc., Cary, NC, USA).
Results
Of 261 patients, 126 (48.3%) had at least one RBC trans-
fusion during their ICU stay (Figure 1). Over the course
of their ICU stay, 46.8% of the patients who were trans-
fused received 5 or more units (Figure 2). Patients who
were transfused were older (68.8 versus 64.1 years),
more likely to be female (47.0% versus 30.7%), sicker
(APACHE II score of 26.8 versus 24.4), and more likely
to have a surgical event precipitating their ICU stay
(21.4% versus 8.9%) (all P < 0.05). The total number of
RBCs transfused per patient ranged from 1 to 64, the
mean was 6.3 (standard deviation of 7.5), and the med-
ian was 4 (interquartile range of 2 to 8). Per transfusion
episode, the mean number of units transfused was 2.4.
Of the 261 patients, 241 were included in our analysis
as we were interested in time-dependent covariates; so
patients with only 1 study day in the ICU or with a pre-
valent DVT or pulmonary embolus were excluded from
the analysis. Baseline demographics are presented in
Table 1.
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Page 3 of 8Occlusive proximal leg DVT was identified in 7
patients, and 7 patients had evidence of chronic venous
abnormalities (consistent with prior DVT) on ICU
admission. During their ICU stay, an additional 25
patients developed proximal leg DVT, ultimately yield-
ing an incidence of 9.6%. Of the 7 acute prevalent and
25 acute incident DVTs, 3 were catheter-related second-
ary to femoral venous access.
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Figure 1 Age distribution of transfused packed red blood cell (RBC) units in storage. The age distribution for all units of RBCs transfused
to patients in this study is shown. ICU, intensive care unit.
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Figure 2 Total number of transfused packed red blood cell (RBC) units. The total number of RBC units transfused in patients during their
intensive care unit (ICU) stay is shown. Data are truncated at 31 units. One patient receiving 64 units is not depicted in the figure.
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Page 4 of 8We first conducted a univariable analysis (Table 2)
testing the association between RBC transfusion and
RBC storage time with DVT, which was non-significant.
In univariable analyses, there was no association
between DVT and RBC temporal exposure to RBCs (1
day earlier, 3 days earlier, 7 days earlier, or ever) or RBC
storage age (not more than 7 or more than 7 days, not
more than 14 or more than 14 days, or not more than
Table 1 Baseline characteristics of patients in regression analysis
Characteristic All (n = 241) RBCs (n = 117) No RBCs (n = 124) P value
Age in years, mean (SD) 66.4 (15.2) 68.8 (13.3) 64.1 (16.5) 0.02
Females, number (percentage) 93 (38.6) 55 (47.0) 38 (30.7) 0.009
APACHE II score, mean (SD) 25.5 (8.4) 26.8 (8.3) 24.2 (8.3) 0.02
Multiple organ dysfunction score, mean (SD) 6.3 (3.9) 7.6 (3.8) 5.1 (3.6) < 0.001
Height in centimeters, mean (SD) 168.7 (10.7) 166.7 (11.4) 170.5 (9.7) 0.007
Weight in kilograms, mean (SD) 76.5 (19.6) 75.4 (19.3) 77.7 (19.9) 0.37
Body mass index in kg/m
2, mean (SD) 27.1 (7.2) 27.4 (7.9) 26.8 (6.4) 0.53
Medical admission, number (percentage) 183 (75.9) 75 (64.1) 108 (87.1) < 0.001
Primary admission diagnosis category, number (percentage)
Pulmonary 89 (36.9) 31 (26.5) 58 (46.8) < 0.001
Cardiovascular 62 (25.7) 37 (31.6) 25 (20.2)
Gastrointestinal 37 (15.4) 24 (20.5) 13 (10.5)
Renal 17 (7.1) 12 (10.3) 5 (4.0)
Neurological 16 (6.6) 2 (1.7) 14 (11.3)
Sepsis 12 (5.0) 7 (6.0) 5 (4.0)
Other
a 8 (3.3) 4 (3.4) 4 (3.2)
Location prior to admission, number (percentage)
Ward 106 (44.0) 53 (45.3) 53 (42.7) 0.002
Emergency room 60 (24.9) 18 (15,4) 42 (33.9)
Operating room 36 (14.9) 25 (21.4) 11 (8.9)
Other hospital ICU 39 (16.2) 21 (18.0) 18 (14.5)
Central venous catheter, number (percentage) 206 (85.5) 110 (94.0) 96 (77.4) < 0.001
Mechanical ventilation, number (percentage) 218 (90.5) 110 (94.0) 108 (87.1) 0.07
Days of mechanical ventilation, median (IQR) 7 (3, 15) 12 (6, 23) 4 (2, 9) < 0.001
Days in ICU, median (IQR) 10 (6, 20) 16 (8, 26) 8 (5, 13) < 0.001
ICU mortality, number (percentage) 66 (27.4) 40 (34.2) 26 (21.0) 0.02
Days in hospital, median (IQR) 25 (13, 54) 30 (15, 64.5) 19 (11, 41) 0.002
Hospital mortality, number (percentage) 94 (39.0) 55 (47.0) 39 (31.5) 0.01
The clinical characteristics of 241 medical-surgical critically ill patients who underwent twice-weekly lower extremity ultrasounds to screen for proximal deep vein
thrombosis and who were included in the regression analysis are shown.
a’Other’ refers to necrotizing fasciitis (3), diabetic ketoacidosis (1), facial surgery (1),
Addison disease (1), mushroom poisoning (1), and post-partum hemorrhage (1). APACHE II, Acute Physiology and Chronic Health Evaluation II; ICU, intensive care
unit; IQR, interquartile range; RBC, packed red blood cell unit; SD, standard deviation.
Table 2 Packed red blood cell unit storage age and deep vein thrombosis incidence: univariable analyses
Temporal relationship to DVT
Age of RBC units Previous day Previous 3 days Previous week Ever before
Any age 1.7 (0.6, 4.4) 1.0 (0.4, 2.4) 1.4 (0.6, 3.3) 1.4 (0.6, 3.3)
≤ 7 days 4.5 (0.6, 35.1) 2.0 (0.3, 15.5) 4.6 (1.3, 17.0) 3.6 (0.9, 14.3)
> 7 days 1.3 (0.4, 4.1) 0.8 (0.3, 2.2) 1.0 (0.4, 2.5) 1.2 (0.5,3.1)
≤ 14 days 1.9 (0.4, 8.4) 1.0 (0.2, 4.2) 1.4 (0.5, 4.3) 1.9 (0.7, 5.1)
> 14 days 1.4 (0.4, 5.0) 0.8 (0.3, 2.5) 1.2 (0.5, 3.0) 1.2 (0.5, 3.1)
≤ 21 days 1.8 (0.6, 5.7) 1.2 (0.4, 3.3) 1.7 (0.7, 4.3) 2.0 (0.8, 5.1)
> 21 days 1.0 (0.1, 7.6) 0.4 (0.1, 3.1) 1.4 (0.5, 4.3) 1.3 (0.4, 3.9)
Data of the 241 patients analyzed and the temporal packed red blood cell (RBC) transfusion thresholds are shown. We present the hazard ratios (with 95%
confidence intervals) for the association between risk of developing a deep vein thrombosis (DVT) in the intensive care unit (ICU) and RBC storage times. This
association was determined by using four sets of data: (1) the data on the previous ICU day to predict DVT, (2) data from any time in the previous 3 days, (3)
data from any time in the previous week in the ICU to predict DVT, and (4) data from any prior ICU day to predict DVT.
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Page 5 of 821 or more than 21 days). Among patients transfused,
no multivariable analyses (Table 3) showed that RBC
transfusion or age predicted DVT. Findings were coun-
ter to the hypothesis generated by prior clinical studies;
for example, RBC storage for not more than 7 days sug-
gested a higher DVT risk compared with more than 7
days (hazard ratio 5.3, 95% CI 1.3 to 22.1).
Discussion
In our study, we found that neither the number of
transfused RBC units nor the duration of RBC storage
affected DVT risk in medical or surgical ICU patients.
Although inflammatory membrane lipid changes on
stored RBCs facilitate thrombin generation, leading
stored RBCs to potentially contribute to a hypercoagul-
able state [9], RBCs stored for not more than 7 days in
our study were associated with a trend toward a higher
risk of DVT compared with RBCs stored more than 7
days.
Possible explanations for our findings include insuffi-
cient power - owing to the relatively low DVT rate - to
detect an association if one truly existed. However, clini-
cally important values are included within our CIs. For
example, the prevalence and incidence of DVT in our
study were 3% and 10%, respectively. A previous study
found that 32% to 40% of ICU patients developed a
DVT [19]. Other potential explanations for the lack of
association between RBC transfusion and DVT in this
study include unmeasured confounders, a difference
between effects on DVT risk in medical or surgical
patients and those in trauma patients, differences in
definition of prolonged storage, and a lack of a true rela-
tionship. Also, we did not include RBC transfusions in
the hospital stay prior to ICU admission. Because our
study design is different from that of the two trauma
studies [12,14], direct comparisons are difficult to make.
Another limitation of our study may be accuracy of the
retrospective collection of the storage age of the trans-
fused RBC units; storage age was obtained by one data
collector and was not verified in duplicate.
The average diameter of RBCs is 7.2 μm, whereas
capillary diameter is 3 to 8 μm. Normal RBCs success-
fully pass through capillary beds because of the ability
to change shape; this capacity is lost in RBC units after
2 or 3 weeks of storage [20] and this loss is not reversi-
ble after 3 weeks of storage [21]. Thus, possible
mechanisms of transfusion-related thrombosis include
lower potential of deformability, higher adherence and
aggregation of RBCs, associated vasoconstriction, or the
presence of a procoagulant substance (related to lipid
release) in the stored supernatant of RBCs stored for
longer than 21 days. However, increased adherence of
RBCs to endothelial cells is demonstrated in stored RBC
u n i t sa n dm a yb em e d i a t e db yt h eR B Cm e m b r a n e
change that increases with time. RBC surface phosphati-
dyl-serine has also been reported to cause platelet acti-
vation and aggregation, which can be prothrombotic
[22,23]. However, the increased adherence of stored
RBC can be abolished by pre-storage leuko-reduction
[24].
The interaction between intra-erythrocyte hemoglobin
and nitric oxide (NO) is also disturbed in older RBC
units [25]. Normal RBCs react almost immediately to
local hypoxia by releasing NO: this causes regional vaso-
dilatation. Conversely, RBCs retain NO if local oxygen
content is adequate: this causes regional vasoconstric-
tion. This function is disturbed within 3 hours of sto-
rage [20]. Moreover, free hemoglobin is released in the
supernatant of stored RBC units [20]. This free hemo-
globin has the potential to retain NO. Thus, older RBC
units may retain NO, causing vasoconstriction and
venous stasis, which may increase the risk of
thrombosis.
Indeed, strong laboratory data suggest that storage
lesion may increase VTE risk after the transfusion of
older RBC units. Conversely, clinical evidence support-
ing an association between RBC age or RBC transfusion
(or both) and DVT is weaker. RBC rheology (deform-
ability and aggregation) is disturbed in patients with
sepsis, and deteriorating rheology is associated with
increased mortality in patients with sepsis [26].
Strengths of our study include consecutive enrollment
of medical or surgical ICU patients, making selection
bias unlikely. We enrolled heterogeneous medical and
surgical critically ill patients, as opposed to solely
trauma patients (which have been previously studied
[12,14]) and this increases the generalizability of our
findings. Transfusion practices were stable over the year
of the study. We considered a broader range of RBC
transfusion volume in comparison with one earlier study
[14] in which only patients transfused more than 5 units
were analyzed. There was a systematic and prospective
monitoring of DVT incidence and this should prevent
any detection bias. DVTs were diagnosed by ultrasound,
Table 3 Red blood cell unit storage age and incidence of
deep vein thrombosis: multivariable analysis
Age of transfused blood Hazard ratio (95% CI) P value
≤ 7 days 5.3 (1.3, 22.1) 0.12
> 7 days 1.0 (0.4, 2.9)
≤ 14 days 1.8 (0.6, 5.1) 0.59
> 14 days 1.2 (0.4, 3.2)
≤ 21 days 2.1 (0.8, 5.5) 0.33
> 21 days 0.9 (0.3, 2.8)
The hazard ratios with 95% confidence intervals (CIs) for the association
between age of blood and acquired risk of deep vein thrombosis in the
intensive care unit are shown.
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symptoms [27]. Each screening ultrasound was con-
ducted independently by credentialed sonographers who
were blinded to patient characteristics and who were
previously shown to have excellent intra-rater reliability
[16]. We adjusted for four previously identified indepen-
dent predictors of DVT [17] in a rigorous multivariable
analysis.
Conclusions
Although higher numbers of transfused RBC units and
prolonged storage of RBCs have been associated with
increased risk of DVT in trauma patients, we did not
observe this association in medical or surgical ICU
patients. Our results do not suggest the need to
decrease the number of transfused units or shorten RBC
storage duration when transfusing RBCs in medical or
surgical critically ill patients. Further studies are needed
to more thoroughly evaluate the possible relationship
between RBC transfusions and VTE in critically ill
patients. Such studies include ABLE (The Age of Blood
Evaluation Trial) (ISRCTN44878718), an ongoing inter-
national randomized trial comparing younger RBCs
(stored fewer than 7 days) with standard-issue RBCs.
Key messages
￿ Inflammatory membrane lipid changes on red
blood cells (RBCs) stored for prolonged periods
facilitate thrombin generation, which may lead to a
potential hypercoagulable state.
￿ Although higher numbers of transfused RBC units
and prolonged storage of RBCs have been associated
with increased risk of deep vein thrombosis (DVT)
in trauma patients, we did not observe this associa-
tion in medical or surgical intensive care unit
patients.
￿ In our study, RBCs stored for fewer than 7 days
were associated with a trend toward a higher risk of
DVT compared with RBCs stored more than 7 days.
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